India to Saudi Arabia: Liraglutide Export Trade Route
India has recorded 1 verified shipments of Liraglutide exported to Saudi Arabia, representing a combined trade value of $152.5K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $152.5K USD. The leading Indian exporter is ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, which accounts for 100% of total export value with 1 shipments worth $152.5K USD. On the buying side, M/S BOSTON ONCOLOGY ARABIA is the largest importer in Saudi Arabia with $152.5K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Saudi Arabia Liraglutide corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $152.5K USD. The route is dominated by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's liraglutide manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $152.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 27.9%, placing it at rank #19 among India's top liraglutide export destinations globally.
On the import side, key buyers of Indian liraglutide in Saudi Arabia include M/S BOSTON ONCOLOGY ARABIA. M/S BOSTON ONCOLOGY ARABIA is the single largest importer with 1 shipments valued at $152.5K USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portHYDERABAD ACC (INHYD4)
Market Position
- Global rank#19
- Annual growth+27.9%
- Demand growth+23.4%
- Regulatory ease66/100
Top 10 Indian Liraglutide Exporters to Saudi Arabia
Showing top 10 of 1 Indian suppliers exporting Liraglutide to Saudi Arabia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI Avg $152.5K per shipment | 1 | $152.5K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting liraglutide to Saudi Arabia, ranked by total trade value. The listed exporters are: ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI is the dominant supplier with 1 shipments worth $152.5K USD, giving it a 100% market share.
Top 10 Liraglutide Importers in Saudi Arabia
Showing top 10 of 1 known buyers in Saudi Arabia receiving Liraglutide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian liraglutide in Saudi Arabia include M/S BOSTON ONCOLOGY ARABIA. The largest importer is M/S BOSTON ONCOLOGY ARABIA, accounting for $152.5K USD across 1 shipments — representing 100% of all liraglutide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S BOSTON ONCOLOGY ARABIA | 1 | $152.5K | 100.0% |
Top 10 Liraglutide Formulations Imported by Saudi Arabia
Showing top 10 of 1 product formulations shipped on the India to Saudi Arabia Liraglutide route, ranked by trade value
Saudi Arabia imports a wide range of liraglutide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ZELYSSA(LIRAGLUTIDE INJECTION,IH,18mg/3mL(6mg/mL)0.6mg,1.2mg or 1.8mg,2.4mg or 3.0mg per Dose)(1848 Packs at 5 Nos per B — accounts for $152.5K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZELYSSA(LIRAGLUTIDE INJECTION,IH,18mg/3mL(6mg/mL)0.6mg,1.2mg or 1.8mg,2.4mg or 3.0mg per Dose)(1848 Packs at 5 Nos per B | 1 | $152.5K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
HYDERABAD ACC (INHYD4) handles the highest volume with 1 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's liraglutide exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI — together account for 100% of total trade value on this route. The average shipment value of $152.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
On the buying side, M/S BOSTON ONCOLOGY ARABIA is the largest importer with 1 shipments worth $152.5K USD — representing 100% of all liraglutide imports from India on this route.
Route Statistics
- Trade Volume
- $152.5K
- Avg. Shipment
- $152.5K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~23 days
- Annual Growth
- +27.9%
Related Analysis
Other Liraglutide Routes
Unlock the Full India to Saudi Arabia Liraglutide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — India to Saudi Arabia Liraglutide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Liraglutide to Saudi Arabia?
The leading Indian exporters of Liraglutide to Saudi Arabia are ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Liraglutide exports from India to Saudi Arabia?
India exports Liraglutide to Saudi Arabia worth approximately $152.5K USD across 1 recorded shipments. The average value per shipment is $152.5K USD.
Q Which ports does India use to ship Liraglutide to Saudi Arabia?
The most active port of origin is HYDERABAD ACC (INHYD4) with 1 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Saudi Arabia for Liraglutide?
The average transit time for Liraglutide shipments from India to Saudi Arabia is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Saudi Arabia Liraglutide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.9% with demand growth tracking at 23.4%. The route is ranked #19 among India's top Liraglutide export destinations globally.
Q How many suppliers are active on the India to Saudi Arabia Liraglutide route?
There are currently 1 active Indian suppliers exporting Liraglutide to Saudi Arabia. The market is moderately concentrated with ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI accounting for 100% of total shipment value.
Q Who are the main importers of Liraglutide from India in Saudi Arabia?
The leading importers of Indian Liraglutide in Saudi Arabia include M/S BOSTON ONCOLOGY ARABIA. M/S BOSTON ONCOLOGY ARABIA is the largest buyer with 1 shipments worth $152.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Saudi Arabia export trade corridor identified from Indian Customs (DGFT) records for Liraglutide.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Saudi Arabia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists